TSNL.F logo

Tristel plcOTCPK:TSNL.F Stock Report

Market Cap US$247.2m
Share Price
US$5.53
US$6.78
18.5% undervalued intrinsic discount
1Yn/a
7D0%
1D
Portfolio Value
View

Tristel plc

OTCPK:TSNL.F Stock Report

Market Cap: US$247.2m

Tristel (TSNL.F) Stock Overview

Develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. More details

TSNL.F fundamental analysis
Snowflake Score
Valuation3/6
Future Growth2/6
Past Performance6/6
Financial Health6/6
Dividends4/6

TSNL.F Community Fair Values

Create Narrative

See what others think this stock is worth. Follow their fair value or set your own to get alerts.

Tristel plc Competitors

Price History & Performance

Summary of share price highs, lows and changes for Tristel
Historical stock prices
Current Share PriceUK£5.53
52 Week HighUK£6.00
52 Week LowUK£5.00
Beta0.33
1 Month Change0%
3 Month Changen/a
1 Year Changen/a
3 Year Change-7.68%
5 Year Changen/a
Change since IPO-7.68%

Recent News & Updates

Recent updates

Shareholder Returns

TSNL.FUS Medical EquipmentUS Market
7D0%6.1%-3.3%
1Yn/a-19.2%22.3%

Return vs Industry: Insufficient data to determine how TSNL.F performed against the US Medical Equipment industry.

Return vs Market: Insufficient data to determine how TSNL.F performed against the US Market.

Price Volatility

Is TSNL.F's price volatile compared to industry and market?
TSNL.F volatility
TSNL.F Average Weekly Movementn/a
Medical Equipment Industry Average Movement8.6%
Market Average Movement7.2%
10% most volatile stocks in US Market16.6%
10% least volatile stocks in US Market3.1%

Stable Share Price: TSNL.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine TSNL.F's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
1993270Matt Sassonetristel.com

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems.

Tristel plc Fundamentals Summary

How do Tristel's earnings and revenue compare to its market cap?
TSNL.F fundamental statistics
Market capUS$247.24m
Earnings (TTM)US$10.52m
Revenue (TTM)US$66.29m
23.5x
P/E Ratio
3.7x
P/S Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TSNL.F income statement (TTM)
RevenueUK£49.54m
Cost of RevenueUK£9.09m
Gross ProfitUK£40.45m
Other ExpensesUK£32.59m
EarningsUK£7.86m

Last Reported Earnings

Dec 31, 2025

Next Earnings Date

n/a

Earnings per share (EPS)0.16
Gross Margin81.66%
Net Profit Margin15.88%
Debt/Equity Ratio0%

How did TSNL.F perform over the long term?

See historical performance and comparison

Dividends

3.7%
Current Dividend Yield
86%
Payout Ratio

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/10 22:31
End of Day Share Price 2026/05/05 00:00
Earnings2025/12/31
Annual Earnings2025/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Tristel plc is covered by 5 analysts. 6 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Christopher DonnellanCavendish
Kane SlutzkinDeutsche Bank
Jens LindqvistInvestec Bank plc (UK)